| dc.contributor.author | Civan, Caner | |
| dc.contributor.author | Kuyumcu, Serkan | |
| dc.contributor.author | Sanli, Yasemin | |
| dc.contributor.author | Karadogan, Seyfullah | |
| dc.contributor.author | Isik, Emine Goknur | |
| dc.date.accessioned | 2023-05-29T12:49:59Z | |
| dc.date.available | 2023-05-29T12:49:59Z | |
| dc.date.issued | 2023 | |
| dc.identifier.citation | Civan C., Isik E. G., Karadogan S., Sanli Y., Kuyumcu S., "68Ga-FAPI-04 PET/CT and 18F-FDG PET/CT in Metastatic Papillary Renal Cell Cancer", Clinical Nuclear Medicine, cilt.48, sa.5, 2023 | |
| dc.identifier.issn | 0363-9762 | |
| dc.identifier.other | av_23aa2bdb-7c44-461f-a089-f3ad966dfec4 | |
| dc.identifier.other | vv_1032021 | |
| dc.identifier.uri | http://hdl.handle.net/20.500.12627/188901 | |
| dc.identifier.uri | https://doi.org/10.1097/rlu.0000000000004587 | |
| dc.identifier.uri | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85151909827&origin=inward | |
| dc.description.abstract | Papillary renal cell cancer is a rare malignancy with limited treatment options in the advanced stage of the disease. We present the case of a 62-year-old man with progressive left-sided papillary renal cell carcinoma who underwent 68Ga-FAPI (fibroblast activated protein inhibitor)-04 and 18F-FDG PET/CT imaging. 68Ga-FAPI-04 PET/CT demonstrated variable FAP expression in all metastatic lesions detected by 18F-FDG PET/CT, including multiple lymph nodes, bone, and thyroid. This case highlights that FAP-Targeted imaging can be a promising modality for diagnostic and theranostic use in papillary renal cell carcinoma. | |
| dc.language.iso | eng | |
| dc.subject | Klinik Tıp (MED) | |
| dc.subject | Klinik Tıp | |
| dc.subject | RADYOLOJİ, NÜKLEER TIP ve MEDİKAL GÖRÜNTÜLEME | |
| dc.subject | Tıp | |
| dc.subject | Dahili Tıp Bilimleri | |
| dc.subject | Sağlık Bilimleri | |
| dc.subject | Nükleer Tıp | |
| dc.subject | Radyoloji, Nükleer Tıp ve Görüntüleme | |
| dc.title | 68Ga-FAPI-04 PET/CT and 18F-FDG PET/CT in Metastatic Papillary Renal Cell Cancer | |
| dc.type | Makale | |
| dc.relation.journal | Clinical Nuclear Medicine | |
| dc.contributor.department | İstanbul Üniversitesi , İstanbul Tıp Fakültesi , Dahili Tıp Bilimleri Bölümü | |
| dc.identifier.volume | 48 | |
| dc.identifier.issue | 5 | |
| dc.contributor.firstauthorID | 4261481 | |
